For Active Immunization against Diphtheria and Tetanus
DESCRIPTION
Diphtheria and Tetanus Vaccine (Adsorbed), (Sii Dual
Antigen) as supplied by Serum Institute of India Ltd. is a sterile,
whitish turibid, uniform suspension of diphtheria and tetanus
toxoids adsorbed on aluminium phosphate and suspended in isotonic
sodium chloride solution.
POTENCY
Each dose of 0.5 ml human dose contains:
Diphtheria Toxoid
|
25
Lf |
| Tetanus Toxoid |
5 Lf |
| Adsorbed on Aluminium Phosphate
(AlPO4) |
1.5 mg |
| Thiomersal |
0.01 % as preservative
|
This vaccine fulfills the I.P. requirements for Diphtheria Toxoid
and Tetanus Toxoid.
INDICATIONS
Diphtheria and Tetanus Vaccine (Adsorbed) is indicated for
the primary immunization of infants, at or above the age of
two months, and of pre-school children against diphtheria and
tetanus in whom simultaneous immunization against pertussis
is not indicated.
DOSAGE
Three injections of 0.5 ml at least four weeks apart followed
by a fourth dose 6 to 12 months later.
For primary immunization of infants and preschool children
it is recommended that three intramuscular injections of 0.5
ml be administered with an interval of four to eight weeks
between doses. A fourth injection of 0.5 ml. should be administered
intramuscularly approximately one year after initial injection.
Although it is recommended that immunization be started at
two to six months of age, if for any reason it is delayed,
the same schedule may be used throughout the preschool period.
A reinforcing injection of 0.5 ml intramuscularly should be
administered between four and six years of age (i.e. at the
time of school entry)
ADMINISTRATION
The vaccine should be administered by intramuscular
injection. The preferred site for injection in infants and
young children is the anterolateral aspect of the upper thigh
or the deltoid muscle in older children.
Only sterile needles and syringes should be used for each
injection. The vaccine should be well shaken before use.
Each injection of the primary immunization series should be
made into a different site.
ADVERSE REACTIONS
Mild local reactions consisting of pain, erythema,
tenderness, and induration at the injection site are common
and may be associated with systemic reactions including
mild to moderate transient fever, and irritability. Persistent
nodules at the site of injection have occurred following
the use of an adsorbed vaccine, but this complication is
unusual
CONTRAINDICATIONS
Diphtheria and Tetanus Vaccine (Adsorbed) should not
be administered to infants or children with high fever,
or other evidence of acute illness.
Elective immunization of individuals over six months of
age should be deferred during an outbreak of poliomyelitis,
Diphtheria and Tetanus Vaccine (Adsorbed) should not be
administered to older children (after six years of age)
or to adults because of the danger of reactions to diphtheria
toxoid.
The specific contraindications adopted by individual national
health authorities should reflect a balance between the
risk from the vaccine and the risk from the disease. Because
the risk from the vaccine remains extremely low in comparison
to the risk from the disease in many developing countries,
authorities there may choose to offer immunization to children
who are mildly to moderately ill or malnourished.
PRECAUTIONS AND WARNING
Individuals receiving corticosteroids or other immunosuppressive
drugs may not develop an optimum immunologic response.
The possibility of allergic reactions in individuals sensitive
to the components of the product should he borne in mind.
Adrenaline injection (1:1000) should be kept ready for immediate
use in case an anaphylactic or acute hypersensitivity reaction
occurs.
Frequent booster doses of tetanus toxoid in the presence
of adequate or excessive serum levels of tetanus antitoxin
have been associated with increased incidence and severity
of reactions and should be avoided. If hypersensitivity
to the diphtheria component is suspected tetanus toxoid
should be used for reinforcing doses. A separate sterile
syringe and needle should be used for each individual, patient
to prevent the transmission of hepatitis or other infectious
agents.
WITHDRAWING THE VACCINE FROM SEALED GLASS AMPOULE
Shake the ampoule to disperse the contents thoroughly immediately
before withdrawing the dose.Tap the ampoule to ensure that
the solution is in the lower portion rather than in the
neck of the ampoule Wipe the neck of the ampoule with a
suitable antiseptic using a sterile piece of cotton break
off the top of the ampoule at the constriction by thumb
pressure.
WITHDRAWING THE VACCINE FROM A RUBBER-STOPPERED VIAL
DO NOT REMOVE THE RUBBER STOPPER FROM THE VIAL
Shake the vial to disperse the contents thoroughly immediately
before each withdrawal of vaccine. Apply a sterile piece
of cotton moistened with a suitable antiseptic to the surface
of the rubber stopper and allow to dry. Draw into the
sterile syringe a volume of air equal to the amount of vaccine
to be withdrawn from the vial .Pierce the centre of the
rubber stopper with the sterile needle of the syringe. invert
the vial, slowly inject into it the air
contained in the syringe, and keeping the point of
the needle immersed withdraw into the syringe
the required amount of vaccine. Then hold the syringe plunger
steady and withdraw the needle from the vial. Carefully insert
the needle intramuscularly at the prepared injection site
In order to avoid intravenous injection, pull back
the plunger of the syringe to make certain that no
blood is withdrawn before injecting the desired
dose.
STORAGE
Diphtheria and Tetanus Vaccine (Adsorbed) should be stored
between 2°C and 8°C (35°F and 46°F). NOT
TO BE FROZEN
Product which has been exposed to freezing should not be used.
PRESENTATION
Diphtheria and Tetanus Vaccine (Adsorbed) is supplied, ready
for use, in rubber-stoppered multi-dose vials, and in single-dose
glass ampoules.
- 0.5 ml X 10 ampoules box
- 5 ml - 10 dose X 50 vials box
|